Cargando…

Changes of healthy brain tissue after salvage radiotherapy of glioblastoma

BACKGROUND: Salvage radiotherapy (SRT) with photons is a valid treatment option for patients suffering from recurrent glioblastoma (GBM). However, the tolerance of healthy brain to ionizing radiation (IR) is limited. The aim of this study was to determine to what extent brain structures in the radio...

Descripción completa

Detalles Bibliográficos
Autores principales:	de la Cruz, Leandra, Chen, Xiaoran, Konugoglu, Ender, Ciernik, I Frank
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Clinical Investigations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8661081/ https://www.ncbi.nlm.nih.gov/pubmed/34901856 http://dx.doi.org/10.1093/noajnl/vdab139

Ejemplares similares

Salvage Radiation Therapy for Patients With Relapsing Glioblastoma Multiforme and the Role of Slow Fractionation
por: Ciernik, I. Frank, et al.
Publicado: (2020)

Bevacizumab-based treatment as salvage therapy in patients with recurrent symptomatic brain metastases
por: Berghoff, Anna Sophie, et al.
Publicado: (2020)

Salvage brachytherapy for multiply recurrent metastatic brain tumors: A matched case analysis
por: Wu, Kyle C, et al.
Publicado: (2022)

Trotabresib (CC-90010) in combination with adjuvant temozolomide or concomitant temozolomide plus radiotherapy in patients with newly diagnosed glioblastoma
por: Vieito, Maria, et al.
Publicado: (2022)

A Dutch phase III randomized multicenter trial: whole brain radiotherapy versus stereotactic radiotherapy for 4–10 brain metastases
por: Hartgerink, Dianne, et al.
Publicado: (2021)

Prognostic Value of TSPO PET Before Radiotherapy in Newly Diagnosed IDH–Wild-Type Glioblastoma
por: Albert, Nathalie L., et al.
Publicado: (2023)

A randomized phase II trial of veliparib, radiotherapy, and temozolomide in patients with unmethylated MGMT glioblastoma: the VERTU study
por: Sim, Hao-Wen, et al.
Publicado: (2021)

Phase II trial of concurrent sunitinib, temozolomide, and radiotherapy with adjuvant temozolomide for newly diagnosed MGMT unmethylated glioblastoma
por: Faye, Mame Daro, et al.
Publicado: (2023)

A randomized phase II trial of efficacy and safety of the immunotherapy ALECSAT as an adjunct to radiotherapy and temozolomide for newly diagnosed glioblastoma
por: Werlenius, Katja, et al.
Publicado: (2021)

Radiotherapy combined with nivolumab or temozolomide for newly diagnosed glioblastoma with unmethylated MGMT promoter: An international randomized phase III trial
por: Omuro, Antonio, et al.
Publicado: (2022)

Assessment of the need for routine intraoperative cell salvage in liver transplantation
por: Lima, Claudianne Maia de Farias, et al.
Publicado: (2023)

Change in volumetric tumor growth rate after cytotoxic therapy is predictive of overall survival in recurrent glioblastoma
por: Oshima, Sonoko, et al.
Publicado: (2023)

Nivolumab plus radiotherapy with or without temozolomide in newly diagnosed glioblastoma: Results from exploratory phase I cohorts of CheckMate 143
por: Omuro, Antonio, et al.
Publicado: (2022)

Chimeric antigen receptors in the brain: Can we tackle glioblastoma with engineered NK cells?
por: Roth, Patrick
Publicado: (2023)

Salvaged single-unit cord blood transplantation for 26 patients with hematologic malignancies not in remission
por: Yao, W., et al.
Publicado: (2015)

Local control and possibility of tailored salvage after hypofractionated stereotactic radiotherapy of the cavity after brain metastases resection
por: Bilger, Angelika, et al.
Publicado: (2018)

Avelumab in newly diagnosed glioblastoma
por: Jacques, Francois H, et al.
Publicado: (2021)

Salvage therapies for radiation-relapsed isocitrate dehydrogenase-mutant astrocytoma and 1p/19q codeleted oligodendroglioma
por: Ma, Sirui, et al.
Publicado: (2021)

MRI phenotypes of glioblastomas early after treatment are suggestive of overall patient survival
por: Schmitz-Abecassis, Bárbara, et al.
Publicado: (2023)

Recurrent Colorectal Liver Metastases in the Liver Remnant After Major Liver Surgery—IRE as a Salvage Local Treatment When Resection and Thermal Ablation are Unsuitable
por: Hitpass, Lea, et al.
Publicado: (2021)

Current usage of tumor treating fields for glioblastoma
por: Lassman, Andrew B, et al.
Publicado: (2020)

Feasibility and tolerability of trofosfamide and etoposide in progressive glioblastoma
por: Schmidt, Teresa, et al.
Publicado: (2023)

Prediction of recurrent glioblastoma after laser interstitial thermal therapy: The role of diffusion imaging
por: Mahammedi, Abdelkader, et al.
Publicado: (2019)

Vascular dysfunction promotes regional hypoxia after bevacizumab therapy in recurrent glioblastoma patients
por: Gerstner, Elizabeth R, et al.
Publicado: (2020)

Combined (18)F-FET PET and diffusion kurtosis MRI in posttreatment glioblastoma: differentiation of true progression from treatment-related changes
por: D’Amore, Francesco, et al.
Publicado: (2021)

Impact of diabetes on gastrointestinal and urinary toxicity after radiotherapy for gynecologic malignancy
por: Özkan, Emine Elif, et al.
Publicado: (2019)

Combination laser interstitial thermal therapy plus stereotactic radiotherapy increases time to progression for biopsy-proven recurrent brain metastases
por: Grabowski, Matthew M, et al.
Publicado: (2022)

Development and Validation of a Multi-institutional Nomogram of Outcomes for PSMA-PET–Based Salvage Radiotherapy for Recurrent Prostate Cancer
por: Zamboglou, Constantinos, et al.
Publicado: (2023)

Predictors of survival in elderly patients undergoing surgery for glioblastoma
por: Voisin, Mathew R, et al.
Publicado: (2021)

Plasma IL-8 and ICOSLG as prognostic biomarkers in glioblastoma
por: Holst, Camilla Bjørnbak, et al.
Publicado: (2021)

Long-term outcomes with reduced-dose whole-brain radiotherapy and a stereotactic radiosurgery boost for primary central nervous system lymphoma
por: Foreman, Bronwen E, et al.
Publicado: (2023)

Prospective biomarker study in newly diagnosed glioblastoma: Cyto-C clinical trial
por: Griguer, Corinne E, et al.
Publicado: (2021)

Visualization of the tumor cavity after lumpectomy of breast cancer for postoperative radiotherapy
por: Ciernik, Ilja F., et al.
Publicado: (2018)

A randomized trial of stereotactic versus conventional radiotherapy in young patients with low-grade brain tumors: occupational therapy-based neurocognitive data
por: Chatterjee, Abhishek, et al.
Publicado: (2020)

Human cytomegalovirus seropositivity is associated with decreased survival in glioblastoma patients
por: Foster, Haidn, et al.
Publicado: (2019)

Multivariate analysis of associations between clinical sequencing and outcome in glioblastoma
por: Yang, Peter H, et al.
Publicado: (2022)

Association of hyperglycemia and molecular subclass on survival in IDH-wildtype glioblastoma
por: Liu, Elisa K, et al.
Publicado: (2022)

Association of Long-term Outcomes and Survival With Multidisciplinary Salvage Treatment for Local and Regional Recurrence After Stereotactic Ablative Radiotherapy for Early-Stage Lung Cancer
por: Brooks, Eric D., et al.
Publicado: (2018)

Population-based analysis of radiation-induced gliomas after cranial radiotherapy for childhood cancers
por: Leary, Jacob B, et al.
Publicado: (2022)

Galactose oxidation using (13)C in healthy and galactosemic children
por: Resende-Campanholi, D.R., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_lskr4tuloi58gpo2nq0ucc5uas